Equities Research Analysts' Updated EPS Estimates for April 22nd (ARCH, ASND, BATS, BBSI, BHB, BME, BMTX, BP, CALX, CCL) : vimarsana.com

Equities Research Analysts’ updated eps estimates for Monday, April 22nd: Arch Resources (NYSE:ARCH) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $180.00 price target on the stock. Ascendis Pharma A/S (NASDAQ:ASND) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $116.00 price target […]

Related Keywords

United States , California , America , American , Roth Mkm , William Blair , Piper Sandler , Raymond James , Ascendis Pharma , Pacific Biosciences , Barrington Research , Equities Research Analyst , Reviva Pharmaceuticals , Healthpeak Properties , Carnival Co , Royce Holdings , Talos Energy , Jefferies Financial Group Inc , Hovde Group , Roivant Sciences , News Ratings For Arch Resources Inc Daily , America Co , Iridium Communications , Morgan Stanley , Barrett Business Services , Marathon Oil , Jpmorgan Chase Co , Lauder Companies , Citigroup Inc , Arch Resources Inc , Needham Company , Lucid Group , Third Bancorp , Lifestance Health Group , Barclays Plc , Vanda Pharmaceuticals , Nasdaq , American Tobacco , Jefferies Financial Group , Business Services , Harbor Bankshares , Financial Group , Chardan Capital , Design Systems , Specialty Products Partners , Stance Health Group , First Financial , Arch Resources Inc Daily , Ascendis Pharmaa S , British American Tobacco Plc , Barrett Business Services Inc , Bar Harbor Bankshares , B Ampm European Value Retail Sa , Bm Technologies Inc , Bp Plc , Calix Inc , Carnival Co Amp Plc ,